Abstract
Iron deficiency anemia is the most common micronutrient deficiency worldwide and infants constitute a risk group due to their high iron requirements. Iron is critical for brain development, and case control studies have shown a consistent association between iron deficiency anemia in infancy and poor neurodevelopment, suggesting that it is important to prevent iron deficiency anemia in infants. However, it is also important to avoid excessive iron intakes which may have adverse effects on growth. Due to redistribution of iron from hemoglobin to iron stores, healthy, term, normal birth weight infants are virtually self-sufficient with regard to iron during the first 6 months of life. After that age, iron becomes a critical nutrient. The estimated daily iron requirements at the age of 6–12 months (0.9–1.3 mg/kg body weight) are higher than during any other period of life. Exclusively breast-fed infants normally do not need additional iron until 6 months of life. Formula-fed infants should receive iron-fortified formula. Low birth weight infants should receive additional iron supplements from an early age. From 6 months of age, all infants should receive a sufficient intake of iron-rich (complementary) foods, which may be meat products or iron-fortified foods. The estimations of iron requirements in infants have a weak evidence base and current European and American recommendations for infants differ significantly. To further clarify iron requirements in infants, there is clearly a need for randomized, controlled trials assessing the effects of different iron intake on anemia, neurodevelopment, and other health outcomes.
References
1.
Mei Z, Cogswell ME, Parvanta I, Lynch S, Beard JL, Stoltzfus RJ, et al: Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials. J Nutr 2005;135:1974–1980.
2.
Domellöf M, Dewey KG, Lönnerdal B, Cohen RJ, Hernell O: The diagnostic criteria for iron deficiency in infants should be re-evaluated. J Nutr 2002;132:3680–3686.
3.
Dobbing J, Sands J: Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3:79–83.
4.
Beard J: Iron deficiency alters brain development and functioning. J Nutr 2003;133(suppl 1):1468S–1472S.
5.
Lozoff B, Brittenham GM, Wolf AW, McClish DK, Kuhnert PM, Jimenez E, et al: Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics 1987;79:981–995.
6.
Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T: Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 2006;64:S34–S43, discussion S72–S91.
7.
Sachdev H, Gera T, Nestel P: Effect of iron supplementation on mental and motor development in children: systematic review of randomised controlled trials. Public Health Nutr 2005;8:117–132.
8.
Szajewska H, Ruszczynski M, Chmielewska A: Effects of iron supplementation in nonanemic pregnant women, infants, and young children on the mental performance and psychomotor development of children: a systematic review of randomized controlled trials. Am J Clin Nutr 2010;91:1684–1690.
9.
Friel JK, Aziz K, Andrews WL, Harding SV, Courage ML, Adams RJ: A double-masked, randomized control trial of iron supplementation in early infancy in healthy term breast-fed infants. J Pediatr 2003;143:582–586.
10.
Lind T, Lönnerdal B, Stenlund H, Gamayanti IL, Ismail D, Seswandhana R, et al: A community-based randomized controlled trial of iron and zinc supplementation in Indonesian infants: effects on growth and development. Am J Clin Nutr 2004;80:729–736.
11.
Moffatt ME, Longstaffe S, Besant J, Dureski C: Prevention of iron deficiency and psychomotor decline in high-risk infants through use of iron-fortified infant formula: a randomized clinical trial. J Pediatr 1994;125:527–534.
12.
Domellöf M: Iron requirements, absorption and metabolism in infancy and childhood. Curr Opin Clin Nutr Metab Care 2007;10:329–335.
13.
Iannotti LL, Tielsch JM, Black MM, Black RE: Iron supplementation in early childhood: health benefits and risks. Am J Clin Nutr 2006;84:1261–1276.
14.
Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, et al: Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 2006;367:133–143.
15.
Dewey KG, Domellöf M, Cohen RJ, Rivera LL, Hernell O, Lönnerdal B: Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras. J Nutr 2002;132:3249–3255.
16.
Widdowson EM, Spray CM: Chemical development in utero. Arch Dis Child 1951;26:205–214.
17.
Oski FA: Iron deficiency in infancy and childhood. N Engl J Med 1993;329:190–193.
18.
Institute of Medicine: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, National Academy Press, 2001.
19.
World Health Organization, Food and Agriculture Organization of the United Nations: Vitamin and Mineral Requirements in Human Nutrition, ed 2. Geneva, World Health Organization, 2004.
20.
Department of Health: Dietary Reference Values for Food Energy and Nutrients for the United Kingdom: Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London, HMSO, 1991.
21.
German Nutrition Society: Reference Values for Nutrient Intakes, ed 1. Bonn, Umschau Braus, 2002.
22.
Australian Government Department of Health and Aging, New Zealand Ministry of Health, National Health and Medical Research Council: Nutrient Reference Values for Australia and New Zealand. Canberra, National Health and Medical Research Council, 2006.
23.
Nordic Council of Ministers: Nordic Nutrition Recommendations 2004: Integrating Nutrition and Physical Activity, ed 4. Copenhagen, Nordic Council of Ministries, 2004.
24.
Berglund S, Westrup B, Domellof M: Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants. Pediatrics 2010;126:e874–e883.
25.
Leong WI, Lönnerdal B: Hepcidin, the recently identified peptide that appears to regulate iron absorption. J Nutr 2004;134:1–4.
26.
Domellöf M, Lönnerdal B, Abrams SA, Hernell O: Iron absorption in breast-fed infants: effect of age, iron status, iron supplements and complementary foods. Am J Clin Nutr 2002;76:198–204.
27.
Hicks PD, Zavaleta N, Chen Z, Abrams SA, Lonnerdal B: Iron deficiency, but not anemia, upregulates iron absorption in breast-fed Peruvian infants. J Nutr 2006;136:2435–2438.
28.
Male C, Persson LA, Freeman V, Guerra A, van’t Hof MA, Haschke F: Prevalence of iron deficiency in 12-mo-old infants from 11 European areas and influence of dietary factors on iron status (Euro-Growth study). Acta Paediatr 2001;90:492–498.
29.
Thane CW, Walmsley CM, Bates CJ, Prentice A, Cole TJ: Risk factors for poor iron status in British toddlers: further analysis of data from the National Diet and Nutrition Survey of children aged 1.5–4.5 years. Public Health Nutr 2000;3:433–440.
30.
Hay G, Sandstad B, Whitelaw A, Borch-Iohnsen B: Iron status in a group of Norwegian children aged 6–24 months. Acta Paediatr 2004;93:592–598.
31.
Bramhagen AC, Axelsson I: Iron status of children in southern Sweden: effects of cow’s milk and follow-on formula. Acta Paediatr 1999;88:1333–1337.
32.
Agostoni C, Decsi T, Fewtrell M, Goulet O, Kolacek S, Koletzko B, et al: Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 2008;46:99–110.
33.
Baker RD, Greer FR: Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics 2010;126:1040–1050.
34.
Domellöf M, Cohen RJ, Dewey KG, Hernell O, Rivera LL, Lönnerdal B: Iron supplementation of breast-fed Honduran and Swedish infants from 4 to 9 months of age. J Pediatr 2001;138:679–687.
35.
Dewey KG, Domellof M, Cohen RJ, Landa Rivera L, Hernell O, Lonnerdal B: Iron supplementation affects growth and morbidity of breast-fed infants: results of a randomized trial in Sweden and Honduras. J Nutr 2002;132:3249–3255.
36.
Koletzko B, Baker S, Cleghorn G, Neto UF, Gopalan S, Hernell O, et al: Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J Pediatr Gastroenterol Nutr 2005;41:584–599.
37.
Domellöf M, Lönnerdal B, Dewey KG, Cohen RJ, Hernell O: Iron, zinc, and copper concentrations in breast milk are independent of maternal mineral status. Am J Clin Nutr 2004;79:111–115.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
